Literature DB >> 30498621

An isolated der(1;21)(q10;q10) translocation in a patient with myelodysplastic syndrome: a case report.

Masahiro Manabe1, Gakuya Tamagaki1, Keiji Shimizu1, Koichi Michimoto1, Yuuji Hagiwara1, Reiko Asada1, Dai Momose1, Yasuyoshi Sugano1, Takeshi Mazaki1, Ki-Ryang Koh1.   

Abstract

Whole-arm translocations are relatively rare among hematological malignancies. There are a few reports on myeloid malignancies harboring der(1;21)(q10;q10). A 65-year-old male was referred to our hospital due to squamous cell carcinoma of the lung. Pembrolizumab monotherapy resulted in progression, and so chemotherapy involving nab-paclitaxel and carboplatin was administered thereafter. The patient developed cytopenia, and his bone marrow exhibited dysplasia. Chromosomal analysis revealed a whole-arm translocation, der(1;21)(q10;q10). Thus, the patient was diagnosed with myelodysplastic syndrome. The der(1;21)(q10;q10) translocation is a rare variant of the der(1;7)(q10;p10) translocation, which is an adverse prognostic factor for myeloid neoplasms. Clarifying the clinical features of myeloid neoplasms in patients with der(1;21)(q10;q10) would facilitate the elucidation of their tumorigenic mechanisms.

Entities:  

Keywords:  der(1;21)(q10;q10); myelodysplastic syndrome; whole-arm translocation

Year:  2018        PMID: 30498621      PMCID: PMC6261837     

Source DB:  PubMed          Journal:  Am J Blood Res        ISSN: 2160-1992


  13 in total

1.  Molecular characterization of the recurrent unbalanced translocation der(1;7)(q10;p10).

Authors:  Lili Wang; Seishi Ogawa; Akira Hangaishi; Ying Qiao; Noriko Hosoya; Yasuhito Nanya; Kazuma Ohyashiki; Hideaki Mizoguchi; Hisamaru Hirai
Journal:  Blood       Date:  2003-06-19       Impact factor: 22.113

Review 2.  Therapy-related myeloid neoplasms: pathobiology and clinical characteristics.

Authors:  H Sill; W Olipitz; A Zebisch; E Schulz; A Wölfler
Journal:  Br J Pharmacol       Date:  2011-02       Impact factor: 8.739

3.  Comparative genomic hybridization and conventional cytogenetic analyses in childhood acute myeloid leukemia.

Authors:  T Huhta; K Vettenranta; K Heinonen; J Kanerva; M L Larramendy; E Mahlamäki; U M Saarinen-Pihkala; S Knuutila
Journal:  Leuk Lymphoma       Date:  1999-10

4.  Structural organization of multiple alphoid subsets coexisting on human chromosomes 1, 4, 5, 7, 9, 15, 18, and 19.

Authors:  P Finelli; R Antonacci; R Marzella; A Lonoce; N Archidiacono; M Rocchi
Journal:  Genomics       Date:  1996-12-15       Impact factor: 5.736

5.  The t(10;11)(p12;q23) translocation in acute leukaemia: a cytogenetic and clinical study of 20 patients. European 11q23 Workshop participants.

Authors:  D M Lillington; B D Young; R Berger; M Martineau; A V Moorman; L M Secker-Walker
Journal:  Leukemia       Date:  1998-05       Impact factor: 11.528

6.  Loss of 17p is a major consequence of whole-arm chromosome translocations in hematologic malignancies.

Authors:  Adewale Adeyinka; Sainan Wei; Jessica Sanchez
Journal:  Cancer Genet Cytogenet       Date:  2007-03

7.  RT-PCR analysis of the MOZ-CBP and CBP-MOZ chimeric transcripts in acute myeloid leukemias with t(8;16)(p11;p13).

Authors:  I Panagopoulos; M Isaksson; C Lindvall; M Björkholm; T Ahlgren; T Fioretos; S Heim; F Mitelman; B Johansson
Journal:  Genes Chromosomes Cancer       Date:  2000-08       Impact factor: 5.006

8.  Fluorescence in situ hybridization analysis of whole-arm 7;12 translocations in hematologic malignancies.

Authors:  B Johansson; K Arheden; M Höglund; A Othzén; A N Békássy; I Turesson; S Heim; F Mitelman
Journal:  Genes Chromosomes Cancer       Date:  1995-09       Impact factor: 5.006

9.  Trisomy 1q in polycythemia vera and its relation to disease transition.

Authors:  B Swolin; A Weinfeld; J Westin
Journal:  Am J Hematol       Date:  1986-06       Impact factor: 10.047

10.  Additional cytogenetic changes and previous genotoxic exposure predict unfavorable prognosis in myelodysplastic syndromes and acute myeloid leukemia with der(1;7)(q10;p10).

Authors:  Hui-Hua Hsiao; Goro Sashida; Yoshikazu Ito; Atsushi Kodama; Katsuyuki Fukutake; Junko H Ohyashiki; Kazuma Ohyashiki
Journal:  Cancer Genet Cytogenet       Date:  2006-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.